Literature DB >> 23000161

Influence of apolipoprotein A-V on hepatocyte lipid droplet formation.

Xuan Gao1, Trudy M Forte, Robert O Ryan.   

Abstract

Apolipoprotein A-V (apoA-V) is postulated to modulate intra-hepatic triglyceride (TG) trafficking. Stably transfected McA-RH7777 hepatocarcinoma cells expressing human apoA-V displayed enhanced neutral lipid staining while conditioned media from these cells had 40±8% less TG than cells transfected with a control vector. To obtain homogeneous cell lines expressing different amounts of apoA-V, a strategy of clonal selection was pursued. Immunoblot analysis of two distinct apoA-V stable cell lines yielded one that expresses low amounts of apoA-V and another that expresses higher amounts. Confocal fluorescence microscopy of control cells and cells expressing low levels of apoA-V had similar numbers of lipid droplets while cells expressing higher amounts of apoA-V had twice as many lipid droplets, on average. Thus, apoA-V expression promotes lipid droplet accumulation in these cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000161      PMCID: PMC3492953          DOI: 10.1016/j.bbrc.2012.09.065

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Underexpressed coactivators PGC1alpha and SRC1 impair hepatocyte nuclear factor 4 alpha function and promote dedifferentiation in human hepatoma cells.

Authors:  Celia P Martínez-Jiménez; M José Gómez-Lechón; José V Castell; Ramiro Jover
Journal:  J Biol Chem       Date:  2006-08-04       Impact factor: 5.157

2.  The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins.

Authors:  Peter J O'Brien; William E Alborn; John H Sloan; Maverick Ulmer; Amechand Boodhoo; Michael D Knierman; Albert E Schultze; Robert J Konrad
Journal:  Clin Chem       Date:  2004-11-04       Impact factor: 8.327

3.  An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.

Authors:  L A Pennacchio; M Olivier; J A Hubacek; J C Cohen; D R Cox; J C Fruchart; R M Krauss; E M Rubin
Journal:  Science       Date:  2001-10-05       Impact factor: 47.728

4.  Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice.

Authors:  Hendrik N van der Vliet; Frank G Schaap; Johannes H M Levels; Roelof Ottenhoff; Norbert Looije; John G Wesseling; Albert K Groen; Robert A F M Chamuleau
Journal:  Biochem Biophys Res Commun       Date:  2002-08-02       Impact factor: 3.575

5.  ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.

Authors:  Frank G Schaap; Patrick C N Rensen; Peter J Voshol; Carlos Vrins; Hendrik N van der Vliet; Robert A F M Chamuleau; Louis M Havekes; Albert K Groen; Ko Willems van Dijk
Journal:  J Biol Chem       Date:  2004-04-16       Impact factor: 5.157

6.  Apolipoprotein A-V association with intracellular lipid droplets.

Authors:  Xiao Shu; Joanne Chan; Robert O Ryan; Trudy M Forte
Journal:  J Lipid Res       Date:  2007-04-25       Impact factor: 5.922

7.  A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum.

Authors:  Hidde L Ploegh
Journal:  Nature       Date:  2007-07-26       Impact factor: 49.962

8.  Structure and interfacial properties of human apolipoprotein A-V.

Authors:  Richard B Weinberg; Victoria R Cook; Jennifer A Beckstead; Dale D O Martin; James W Gallagher; Gregory S Shelness; Robert O Ryan
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

Review 9.  Lipid droplets: a unified view of a dynamic organelle.

Authors:  Sally Martin; Robert G Parton
Journal:  Nat Rev Mol Cell Biol       Date:  2006-05       Impact factor: 94.444

10.  Nile red: a selective fluorescent stain for intracellular lipid droplets.

Authors:  P Greenspan; E P Mayer; S D Fowler
Journal:  J Cell Biol       Date:  1985-03       Impact factor: 10.539

View more
  9 in total

1.  Apolipoprotein A-V deficiency enhances chylomicron production in lymph fistula mice.

Authors:  Linda S Zhang; Min Xu; Qing Yang; Robert O Ryan; Philip Howles; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-23       Impact factor: 4.052

2.  Gene transfer of apolipoprotein A-V improves the hypertriglyceridemic phenotype of apoa5 (-/-) mice.

Authors:  Vineeta Sharma; Jennifer A Beckstead; Jens B Simonsen; Lisa Nelbach; Gordon Watson; Trudy M Forte; Robert O Ryan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-17       Impact factor: 8.311

Review 3.  Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol.

Authors:  Vineeta Sharma; Trudy M Forte; Robert O Ryan
Journal:  Curr Opin Lipidol       Date:  2013-04       Impact factor: 4.776

4.  Implication between Genetic Variants from APOA5 and ZPR1 and NAFLD Severity in Patients with Hypertriglyceridemia.

Authors:  Virginia Esteve-Luque; Ariadna Padró-Miquel; Marta Fanlo-Maresma; Emili Corbella; Xavier Corbella; Xavier Pintó; Beatriz Candás-Estébanez
Journal:  Nutrients       Date:  2021-02-08       Impact factor: 5.717

5.  Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway.

Authors:  Min-Jie Lin; Wen Dai; Melanie J Scott; Rong Li; Yi-Qi Zhang; Yang Yang; Lu-Zhu Chen; Xian-Sheng Huang
Journal:  Oncotarget       Date:  2017-10-30

Review 6.  The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases.

Authors:  Amin Hasanvand
Journal:  Inflammopharmacology       Date:  2022-04-13       Impact factor: 4.473

7.  Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine.

Authors:  Piao-Piao Huang; Wen-Qiang Zhu; Jing-Mei Xiao; Yi-Qi Zhang; Rong Li; Yang Yang; Li Shen; Fei Luo; Wen Dai; Ping-An Lian; Ya-Xin Tang; Juan-Li Ran; Xian-Sheng Huang
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

Review 8.  Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease.

Authors:  Wen Dai; Ziyu Zhang; Chun Yao; Shuiping Zhao
Journal:  Lipids Health Dis       Date:  2019-12-13       Impact factor: 3.876

Review 9.  Metabolic-associated fatty liver disease and lipoprotein metabolism.

Authors:  Joerg Heeren; Ludger Scheja
Journal:  Mol Metab       Date:  2021-04-20       Impact factor: 7.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.